losartan has been researched along with Carditis in 7 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether losartan has protective effects in mice with chronic viral myocarditis induced by coxsackievirus B3 (CVB3)." | 7.79 | Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. ( Li, JN; Miao, SK; Wu, YY; Xia, HH; Zhang, SL; Zhang, YY; Zhong, J; Zhou, LM, 2013) |
| "Losartan, a recently developed nonpeptide angiotensin II (AII) receptor antagonist, was orally administered for 14 days to mice with viral myocarditis, beginning 7 days after encephalomyocarditis virus inoculation." | 7.69 | Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. ( Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T, 1995) |
| "To investigate whether losartan has protective effects in mice with chronic viral myocarditis induced by coxsackievirus B3 (CVB3)." | 3.79 | Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. ( Li, JN; Miao, SK; Wu, YY; Xia, HH; Zhang, SL; Zhang, YY; Zhong, J; Zhou, LM, 2013) |
| " Treatment with losartan significantly attenuated TAC-induced cardiac hypertrophy, in parallel with decreased expression of RANKL, TNF-α, IL-1α, and IL-1β." | 3.78 | Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation. ( Abel, ED; Ahn, J; Kim, HS; Kim, J; Lee, SH; Lee, WS; Min, JK; Ock, S; Oh, GT; Oh, JG; Park, H; Park, WJ; Rho, J; Son, JW; Yang, DK, 2012) |
| "The angiotensin converting enzyme inhibitor captopril prevents myosin-induced experimental autoimmune myocarditis." | 3.74 | Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis. ( Bahk, TJ; Daniels, MD; Engman, DM; Leon, JS; Wang, K, 2008) |
| "Animals were divided into three groups: myocarditis, myocarditis intervened by Losartan, and normal control." | 3.70 | [Preventional intervention of myocardial interstitial fibrosis in murine myocardium with acute myocarditis]. ( Cheng, X; Jing, Z; Yang, Y, 1998) |
| "Losartan, a recently developed nonpeptide angiotensin II (AII) receptor antagonist, was orally administered for 14 days to mice with viral myocarditis, beginning 7 days after encephalomyocarditis virus inoculation." | 3.69 | Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. ( Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T, 1995) |
| "Coxiella burnetii myocarditis is a rare but severe clinical form of acute Q fever." | 1.31 | [Acute myocardial failure in a young man: Q-fever myocarditis]. ( Climent, V; López, I; Manso, MI; Murcia, J; Reus, S; Tello, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Zijll Langhout, M | 1 |
| Wolters, M | 1 |
| Horvath, KM | 1 |
| Thiesbrummel, H | 1 |
| Smits, P | 1 |
| van Bolhuis, H | 1 |
| van der Hulst, V | 1 |
| Riezebos, R | 1 |
| Zhang, YY | 1 |
| Li, JN | 1 |
| Xia, HH | 1 |
| Zhang, SL | 1 |
| Zhong, J | 1 |
| Wu, YY | 1 |
| Miao, SK | 1 |
| Zhou, LM | 1 |
| Ock, S | 1 |
| Ahn, J | 1 |
| Lee, SH | 1 |
| Park, H | 1 |
| Son, JW | 1 |
| Oh, JG | 1 |
| Yang, DK | 1 |
| Lee, WS | 1 |
| Kim, HS | 1 |
| Rho, J | 1 |
| Oh, GT | 1 |
| Abel, ED | 1 |
| Park, WJ | 1 |
| Min, JK | 1 |
| Kim, J | 1 |
| Murcia, J | 1 |
| Reus, S | 1 |
| Climent, V | 1 |
| Manso, MI | 1 |
| López, I | 1 |
| Tello, A | 1 |
| Bahk, TJ | 1 |
| Daniels, MD | 1 |
| Leon, JS | 1 |
| Wang, K | 1 |
| Engman, DM | 1 |
| Araki, M | 1 |
| Kanda, T | 1 |
| Imai, S | 1 |
| Suzuki, T | 1 |
| Murata, K | 1 |
| Kobayashi, I | 1 |
| Jing, Z | 1 |
| Cheng, X | 1 |
| Yang, Y | 1 |
7 other studies available for losartan and Carditis
| Article | Year |
|---|---|
Clinical signs, diagnostics and successful treatment of a myocarditis in an adult chimpanzee (Pan troglodytes).
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Ape Diseases; Carbazoles; Carvedilol; | 2017 |
Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.
Topics: Animals; Animals, Newborn; Antiviral Agents; Cardiotonic Agents; Cells, Cultured; Coxsackievirus Inf | 2013 |
Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Antibodies, Monoclonal; Antibodi | 2012 |
[Acute myocardial failure in a young man: Q-fever myocarditis].
Topics: Acute Disease; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibodies, Bacterial; Cardiomy | 2002 |
Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoanti | 2008 |
Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Topics: Acute Disease; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihyperten | 1995 |
[Preventional intervention of myocardial interstitial fibrosis in murine myocardium with acute myocarditis].
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Fibrosis; Losartan; Male; Mice; Mice, Inbr | 1998 |